Tech Company Inital Public Offerings
Galapagos NV IPO
Galapagos NV, operating out of Mechelen, debuted as a public company on 6/3/2005.
Transaction Overview
Company Name
Announced On
6/3/2005
Transaction Type
IPO
Amount
$22,400,000
Proceeds Purpose
To further develop their drugs for rheumatoid arthritis, osteoporosis and osteoarthritis and bring them to the clinic for at least two years
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Generaal De Wittelaan L11 A3
Mechelen, 2800
Belgium
Mechelen, 2800
Belgium
Phone
Website
Email Address
Overview
Galapagos aim is to make a lasting contribution to society through discovery of breakthrough therapies for diseases with large unmet medical need.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Onno Stolpe
Chief Financial Officer
Bart Filius
Chief Medical Officer
Walid Abi-Saab
Chief Scientific Officer
Piet Wigerinck
VP - Bus. Development
Andre Hoekema
Browse more venture capital transactions:
Prev: 6/3/2005: Klir Technologies venture capital transaction
Next: 6/3/2005: MedVantx venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs